English
Polski
Español
українська
русский
Sulfonylureas in diabetes
Is there still a place for sulfonylureas in the management of older patients with diabetes?
2019-11-08
Is there still a place for sulfonylureas in the management of older patients with diabetes?
Does insulin therapy in patients with type 2 diabetes always increase the risk of weight gain? Can weight gain be prevented?
Should other antidiabetic agents be discontinued when starting insulin therapy in a patient with type 2 diabetes?
Are there any known risk factors for the development of autoimmune (Hashimoto) thyroiditis?
Which insulin treatment regimen is preferred in patients with type 2 diabetes? What factors should be considered when selecting the regimen?
Can iodine deficiency influence the incidence of follicular thyroid cancer in the general population?
Is it possible to avoid insulin therapy in patients with long-standing type 2 diabetes?
Can a thyroid nodule >1 cm in diameter be considered benign if it does not show signs of growth on repeated ultrasonography?
In a patient with type 2 diabetes, should insulin be always started from once daily administration or can a 2- or 4-injection regimen be used up front?
Does starting insulin in a patient with type 2 diabetes implicate lifelong insulin treatment?
McMaster Textbook of Internal Medicine acknowledges the important contribution of Cochrane Canada and its authors in development of the textbook.